112 related articles for article (PubMed ID: 3039513)
1. Role of antibodies to murine leukemia virus p15E transmembrane protein in immunotherapy against AKR leukemia: a model for studies in human acquired immunodeficiency syndrome.
Thiel HJ; Schwarz H; Fischinger P; Bolognesi D; Schäfer W
Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5893-7. PubMed ID: 3039513
[TBL] [Abstract][Full Text] [Related]
2. Properties of mouse leukemia viruses. XVII. Factors required for successful treatment of spontaneous AKR leukemia by antibodies against gp71.
Schwarz H; Ihle JN; Wecker E; Fischinger PJ; Thiel HJ; Bolognesi DP; Schäfer W
Virology; 1981 Jun; 111(2):568-78. PubMed ID: 6264673
[No Abstract] [Full Text] [Related]
3. [Spontaneous leukemia of AKR mice. Successful passive immunization with goat antibodies against isolated glycoprotein gp71 of Friend leukemia virus].
Schwarz H; Thiel HJ; Schäfer W
Z Naturforsch C Biosci; 1977; 32(5-6):459-61. PubMed ID: 141818
[TBL] [Abstract][Full Text] [Related]
4. Properties of mouse leukemia viruses. XIX. Effective antibody therapy of AKR leukemia occurs independently of virus neutralization and produces long-term changes in the virus status of the thymus.
Weinhold KJ; Hüper G; Matthews TJ; Fischinger PJ; Ihle JN; Schwarz H; Thiel HJ; Schäfer W; Bolognesi DP
Virology; 1984 May; 135(1):105-17. PubMed ID: 6328742
[TBL] [Abstract][Full Text] [Related]
5. XVIII. Effective treatment of AKR leukemia with antibody to gp7 1 eliminates the neonatal burst of ecotropic AKR virus producing cells.
Fischinger PJ; Dunlop NM; Schwarz H; Ihle JN; Weinhold K; Bolognesi DP; Schafer W
Virology; 1982 May; 119(1):68-81. PubMed ID: 6280386
[No Abstract] [Full Text] [Related]
6. The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus.
Lee JC; Ihle JN; Huebner R
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):343-7. PubMed ID: 189311
[TBL] [Abstract][Full Text] [Related]
7. Subunit vaccines against exogenous retroviruses: overview and perspectives.
Hunsmann G
Cancer Res; 1985 Sep; 45(9 Suppl):4691s-4693s. PubMed ID: 2410114
[TBL] [Abstract][Full Text] [Related]
8. Surface expression of murine leukemia virus structural polypeptides on host cells and the virion.
Schneider J; Hunsmann G
Int J Cancer; 1978 Aug; 22(2):204-13. PubMed ID: 81184
[TBL] [Abstract][Full Text] [Related]
9. Properties of mouse leukemia viruses: XX. Variation of AKR Substrains in response to antibody therapy.
Schwarz H; Thiel HJ; Weinhold K; Fischinger P; Bolognesi D; Schäfer W
Virology; 1986 Apr; 150(1):247-51. PubMed ID: 3952985
[TBL] [Abstract][Full Text] [Related]
10. The role of bone marrow and thymic elements in the initiation and spread of virus production in the AKR thymus.
Buckheit RW; Bolognesi DP; Weinhold KJ
Virology; 1988 Oct; 166(2):533-41. PubMed ID: 3176345
[TBL] [Abstract][Full Text] [Related]
11. The effects of leukemosuppressive immunotherapy on bone marrow infectious cell centers in AKR mice.
Buckheit RW; Bolognesi DP; Weinhold KJ
Virology; 1987 Apr; 157(2):387-96. PubMed ID: 3029979
[TBL] [Abstract][Full Text] [Related]
12. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
Bekesi JG; Roboz JP; Zimmerman E; Holland JF
Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to the envelope protein (gp70) of endogenous xenotropic and ecotropic leukemia viruses: induction by immunization with leukemia cells.
Boiocchi M; Nowinski RC
Virology; 1979 Jul; 96(1):281-5. PubMed ID: 88799
[No Abstract] [Full Text] [Related]
14. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus.
Genovesi EV; Collins JJ
J Cell Physiol; 1983 Nov; 117(2):215-29. PubMed ID: 6630299
[TBL] [Abstract][Full Text] [Related]
15. [Stimulation of immunoreactivity against endogenous retroviruses and protection against leukemia in aged AKR mice after vaccination with antibodies to viral surface components. The role of antibodies to p15(E)].
Schwarz H; Thiel HJ; Weinhold KJ; Bolognesi DP; Schäfer W
Z Naturforsch C Biosci; 1984; 39(11-12):1199-202. PubMed ID: 6531950
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of mouse leukemia with monoclonal antibodies directed against type-C virus structural proteins.
Boiocchi M; Mondellini P
Tumori; 1984 Feb; 70(1):9-16. PubMed ID: 6324432
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of normal mouse lymphocyte mitogen responses by xenogeneic or allogeneic antibodies to the MuLV glycoprotein gp71.
Lee JC; Ihle JN
J Immunol; 1976 Sep; 117(3):1033-8. PubMed ID: 182879
[TBL] [Abstract][Full Text] [Related]
18. Prevention of spontaneous leukemia in AKR mice by passive immunization and type specificity of this protection.
Fish DC; Gilden RV; Bare RM; Trimmer RM; Huebner RJ
J Natl Cancer Inst; 1979 Apr; 62(4):943-5. PubMed ID: 219284
[TBL] [Abstract][Full Text] [Related]
19. Prevention of spontaneous leukemia in AKR mice by type-specific immunosuppression of endogenous ecotropic virogenes.
Huebner RJ; Gilden RV; Toni R; Hill RW; Trimmer RW; Fish DC; Sass B
Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4633-5. PubMed ID: 188047
[TBL] [Abstract][Full Text] [Related]
20. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
Manjunath R; Graziano RF; Green WR
J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
